How flu succeeds: Investigators identify host factors that help multiple influenza strains thrive

December 22, 2009

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1. The team also identified small molecule compounds that act on several of these factors and inhibit viral replication, pointing to new ways to treat flu. These findings were published online on December 21 in the journal Nature.

Influenza A virus contains only enough genetic information (RNA) to produce 11 proteins and must co-opt host to complete its life cycle. Sumit Chanda, Ph.D., of Burnham, Megan Shaw, Ph.D., of Mount Sinai, John Young, Ph.D., of Salk, Yingyao Zhou, Ph.D., of GNF and others used RNAi screening technology to selectively turn off more than 19,000 human genes to determine which human factors facilitate viral entry, uncoating, nuclear import, and other necessary functions of the virus.

"Because influenza mutates so readily, it has become a moving target for therapeutic intervention, making it difficult to treat circulating strains, including the H1N1 ," said Dr. Chanda. "As a result, there is now widespread resistance to two classes of antiviral drugs. However, by targeting more stable human host factors, we may be able to develop therapies that prevent or treat a variety of strains and are more likely to maintain their effectiveness."

"This study has provided us with crucial knowledge of the cellular pathways and factors the influenza virus exploits to replicate" added Dr. Shaw. "Each of these represents an 'Achilles heel' of the virus and vastly increases the number of potential targets for new influenza antiviral drugs."

The team screened human A549 (lung epithelial) cells infected with a modified against the genome-wide siRNA library. Conducting two independent screens, they confirmed that selectively impairing each of 295 cellular genes reduced viral infection, effectively illuminating the path followed by influenza viruses during the infection of a cell. Importantly, they found that inhibiting proteins in known drug target classes, such as kinases, vATPases, and tubulin, impairs influenza growth, suggesting that small molecular weight compounds may be developed as host factor-directed antivirals. Protein interactions dataset analysis confirmed 181 host cellular factors that mediate 4,266 interactions between viral or cellular proteins.

Renate Koenig, Ph.D., of Burnham and Peter Palese, Ph.D., Silke Stertz, Ph.D., and Adolfo Garcia-Sastre, Ph.D., of Mount Sinai also collaborated on this research.

"Trying to identify all the host proteins that are required for the replication of viruses is a wonderful challenge and we have come closer to 'knowing' all the genes involved," said Dr. Palese.

Dr. Young added, "These findings, combined with those from other RNAi screens, provide a blueprint of the cellular processes that are exploited more generally by viruses, pointing towards development of future broad-spectrum antiviral approaches."

Explore further: Evolution of influenza A virus

Related Stories

Evolution of influenza A virus

December 1, 2006

An understanding of the evolutionary dynamics of the influenza virus determines scientists' ability to survey and control the virus.

Influenza spreads readily in winter conditions

October 19, 2007

Low temperatures and relative humidities have been linked to the rapid spread of influenza in a new study by researchers, led by Dr. Peter Palese, from the Mount Sinai School of Medicine. The study, published in PLoS Pathogens, ...

Getting wise to the influenza virus' tricks

May 4, 2008

Influenza is currently a grave concern for governments and health organisations around the world. The worry is the potential for highly virulent bird flu strains, such as H5N1, to develop the ability to infect humans easily. ...

Recommended for you

A novel toxin for M. tuberculosis

August 4, 2015

Despite 132 years of study, no toxin had ever been found for the deadly pathogen Mycobacterium tuberculosis, which infects 9 million people a year and kills more than 1 million.

New biosensors for managing microbial 'workers'

August 4, 2015

Super productive factories of the future could employ fleets of genetically engineered bacterial cells, such as common E. coli, to produce valuable chemical commodities in an environmentally friendly way. By leveraging their ...

Fish that have their own fish finders

August 4, 2015

The more than 200 species in the family Mormyridae communicate with one another in a way completely alien to our species: by means of electric discharges generated by an organ in their tails.

Volcanic bacteria take minimalist approach to survival

August 4, 2015

New research by scientists at the University of Otago and GNS Science is helping to solve the puzzle of how bacteria are able to live in nutrient-starved environments. It is well-established that the majority of bacteria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.